When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - FDA grants accelerated review for expanded use of Xtandi
Astellas Pharma Inc
Astellas Pharma (OTCPK:ALPMF) and collaboration partner Pfizer (PFE+1%) announce that the FDA has granted Priority Review status for the latter's supplemental marketing application for Xtandi (enzalutamide) for the treatment of metastatic hormone-sensitive prostate cancer.
More news on: Astellas Pharma Inc., Pfizer Inc., Astellas Pharma Inc., Healthcare stocks news,